Johnson & Johnson Tops revenue Estimates however Trims Full-yr gross sales steering



Johnson & Johnson


third-quarter adjusted earnings topped analysts’ estimates however the healthcare large reduce its gross sales steering for the yr.



Johnson & Johnson


(ticker: JNJ) posted adjusted earnings of $2.fifty five a share on gross sales of $23.eight billion.

Sourcelink

Comments